Skip to main content

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Liberty Health Sciences Inc. (LHS-C) announced the sale, through its subsidiaries, of certain of its assets in Florida and substantially all of its assets in Ohio for US$14.75-million to an arm’s length purchaser.

Liberty said it has shifted its focus to its campus in Gainesville, Florida. "Our primary focus has been on expanding Liberty 360 facility located in Gainesville," said Victor Mancebo, interim CEO of Liberty.

Story continues below advertisement

**

Maxar Technologies Inc. (MAXR-N; MAXR-T) announced that its MDA division has been awarded two contracts from the Canadian Space Agency for work on Phase A of the Gateway External Robotic Interfaces project. “MDA is proud to continue our legacy of working with the Canadian Space Agency and its international partners to design, build and deploy robotic systems in support of space exploration missions,” said Mike Greenley, group president of MDA.

**

Morneau Shepell Inc. (MSI-T) announced Grier Colter has been appointed the company’s chief financial officer and executive vice president, effective Oct. 1. With Colter’s appointment, Scott Milligan will move to a role as chief corporate officer and executive vice president, the company stated.

**

Transat A.T. Inc. (TRZ-T) issued a statement to confirm that it has taken note of Pierre Karl Péladeau’s Monday announcement that he will vote against the arrangement for Air Canada to take over the company and consider making a separate offer with partners if the deal fails. “Transat notes that pursuant to this press release, no offer to acquire Transat has been made by Mr. Péladeau or any of his business associates,” the company stated while reiterating its support for the Air Canada offer.

**

Story continues below advertisement

AgraFlora Organics International Inc. (AGRA-C) announced an agreement to acquire 50 per-cent of the issued and outstanding shares of Eurasia Infused Cosmetics Inc. “AgraFlora and Eurasia will collaborate to integrate the company’s vertically integrated, farm-to-face CBD processing, manufacturing and distribution model into the Asia Pacific region,” the company stated.

AgraFlora will acquire the stake in exchange for 15 million common shares in the capital of the company, based upon the five-day volume-weighted average price of AgraFlora common shares for the five trading sessions prior to the announcement of the definitive agreement.

**

K92 Mining Inc. (KNT-X) issued a statement to update to shareholders regarding the trading activity of its common shares on the TSX Venture Exchange and OTCQX on Aug. 19. The stock closed down 18 per cent to $2.09 on Monday.

"K92 is aware of various media reports on recent negotiations between Barrick Gold Corporation and the Government of Papua New Guinea relating to the renewal of the special mining lease for the Porgera Mine," the company stated. "While K92 is not a party to those negotiations and has no affiliations with the Porgera Mine, K92 believes that some of these reports may have inadvertently caused some confusion and contributed to recent volatility in the company’s share price.

K92’s mining lease and license for mining purpose are not subject to any renewal discussion, the company stated, “and are not due for renewal until June 13, 2024, at which time the Company has the right to renew the mining leases subject to Papua New Guinea mining regulations.”

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter